SCHEMBL12426593

SCHEMBL12426593

CCN(C)[C@@H](C)[C@H](OC)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
AOC3 Q16853 4/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 3/20 0.40
HTR2A P28223 3/20 0.39
HRH1 P35367 3/20 0.39
TDP1 Q9NUW8 1/20 0.38
CYP2D6 P10635 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
KCNH2 Q12809 3/20 0.38
LMNA P02545 3/20 0.37
SIGMAR1 Q99720 1/20 0.37
CYP1A2 P05177 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
ADRA2A P08913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6695667 1.00 THRB (0.46) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL12386523 0.86 THRB (0.44) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL6686136 0.84 HTR2A (0.50) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL6686484 0.84 HTR2A (0.40) AOC3KDM4EALDH1A1HTR2AHRH1
SCHEMBL6692689 0.82 ALDH1A1 (0.53) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL12319469 0.82 ALDH1A1 (0.53) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL6689517 0.79 THRB (0.47) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL13802349 0.75 THRB (0.35) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL13802352 0.75 THRB (0.35) THRBAOC3KDM4EALDH1A1CYP3A4
SCHEMBL5474344 0.75 THRB (0.57) THRBALDH1A1CYP3A4HTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994355-B2 Metallocene-based chiral phosphine or arsine ligands SOLVIAS AG (CH) 2011-08-09 US disclosed
EP-1709054-B1 METALLOCENE-BASED CHIRAL PHOSPHINE OR ARSINE LIGANDS PHOENIX CHEMICALS LTD (GB) 2009-03-04 EP disclosed
US-20070161762-A1 Metallocene-based chiral phosphine or arsine ligands PHOENIX CHEMICALS LIMITED (GB) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161762-A1 Metallocene-based chiral phosphine or arsine ligands OSGEP, PHOSPHO1, ITPA THRB 2928/4885AOC3 1457/4885KDM4E 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.